Central Pacific Bank - Trust Division’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$189K Buy
2,418
+168
+7% +$13.6K 0.02% 486
2026
Q1
$195K Sell
2,250
-50
-2% -$4.79K 0.02% 456
2025
Q4
$221K Hold
2,300
0.03% 423
2025
Q3
$219K Hold
2,300
0.03% 428
2025
Q2
$200K Hold
2,300
0.03% 436
2025
Q1
$207K Sell
2,300
-200
-8% -$17.9K 0.03% 436
2024
Q4
$200K Buy
2,500
+89
+4% +$7.71K 0.03% 444
2024
Q3
$217K Buy
2,411
+311
+15% +$26.2K 0.03% 443
2024
Q2
$165K Hold
2,100
0.02% 584
2024
Q1
$183K Buy
+2,100
New +$179K 0.02% 560

Other funds holding MDT

Central Pacific Bank - Trust Division's MDT Position: Q2 2026 in Review

Central Pacific Bank - Trust Division increased its Medtronic (MDT) stake by 7.5% in Q2 2026, buying an estimated $13.6K and bringing the position to 2,418 shares worth $189K. The position accounts for 0.02% of the portfolio, ranked #486.

Central Pacific Bank - Trust Division first reported a position in MDT in Q1 2024 and has held it in 10 quarters since. The position peaked at $221K in Q4 2025. 606 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Central Pacific Bank - Trust Division held 2,418 shares of Medtronic worth $189K as of Q2 2026.
  • Central Pacific Bank - Trust Division bought 168 Medtronic shares in Q2 2026, an estimated $13.6K.
  • Medtronic made up 0.02% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #486 holding.
  • Central Pacific Bank - Trust Division first reported a position in Medtronic in Q1 2024 and has held it in 10 quarters since.
  • Central Pacific Bank - Trust Division's Medtronic position peaked at $221K in Q4 2025.
  • 606 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.